CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $603,153 | -15.9% | 21,505 | 0.0% | 0.12% | -22.0% |
Q2 2023 | $717,407 | -27.2% | 21,505 | 0.0% | 0.16% | -57.4% |
Q4 2022 | $985,359 | -7.2% | 21,505 | +3.6% | 0.37% | +43.5% |
Q3 2022 | $1,062,000 | +19.3% | 20,755 | -4.6% | 0.26% | +33.3% |
Q2 2022 | $890,000 | +11.1% | 21,755 | 0.0% | 0.20% | +25.0% |
Q1 2022 | $801,000 | -19.4% | 21,755 | 0.0% | 0.16% | -9.3% |
Q4 2021 | $994,000 | +18.2% | 21,755 | 0.0% | 0.17% | +12.4% |
Q3 2021 | $841,000 | +97.9% | 21,755 | 0.0% | 0.15% | +84.3% |
Q2 2021 | $425,000 | -16.3% | 21,755 | 0.0% | 0.08% | -22.4% |
Q1 2021 | $508,000 | +20.7% | 21,755 | 0.0% | 0.11% | +11.5% |
Q4 2020 | $421,000 | +1.9% | 21,755 | -11.4% | 0.10% | -14.3% |
Q3 2020 | $413,000 | +184.8% | 24,555 | +102.0% | 0.11% | -21.1% |
Q1 2020 | $145,000 | – | 12,155 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |